Only show
results from:

Sort results by:

Display preferences
242 results sorted by relevancy Results per page:
Aphton Corp. Announces Start of Phase III Clinical Trials Program for GI Cancers with Gastrimmune.
Business Wire; Jul 23, 1996; 700+ Words ...BUSINESS WIRE)--July 23, 1996--Aphton Corp. (NASDAQ: APHT) announced that...generated by the tumor cells. Aphton Corp. is a biopharmaceutical company...Organization (WHO). CONTACT: Aphton Corp. J. L. Whitmore, 305/374...
The Aphton Corp Latest Product Pipeline Report Provides An Unbiased, Accurate, Independent Approach To Company Analysis.
M2 Presswire; Nov 7, 2007; 700+ Words ...2007-Research and Markets: The Aphton Corp Latest Product Pipeline Report...has announced the addition of "Aphton Corp - Product Pipeline Report" to their offering The Aphton Corp Latest Product Pipeline Report...
Research and Markets: Aphton Corp - Deals and Alliances Report Provide an Unbiased, Accurate, Independent Approach to Company Analysis, Whether for Partnering or Investment Purposes.
Business Wire; Feb 7, 2007; 700+ Words ...has announced the addition of "Aphton Corp - Deals and Alliances Report" to their offering. The Aphton Corp Deals & Alliances Report...date information available. The Aphton Corp - Deals and Alliances Report therefore...
Research and Markets: The Aphton Corp Latest Product Pipeline Report Provides an Unbiased, Accurate, Independent Approach to Company Analysis.(Report)
Business Wire; Nov 7, 2007; 700+ Words ...has announced the addition of "Aphton Corp - Product Pipeline Report" to their offering. The Aphton Corp Latest Product Pipeline Report...date information available. The Aphton Corp Product Pipeline Report therefore...
Aphton Corp.(APHT) - Quantitative Valuation Report.
M2 Presswire; Feb 20, 2003; 700+ Words ...PRESSWIRE-20 February 2003-Research and Markets: Aphton Corp.(APHT) - Quantitative Valuation Report(C)1994-2003 M2 COMMUNICATIONS LTD RDATE:02192003 Company Name - Aphton Corp. Now you, as an individual investor or investment professional...
Aphton Corp. Successfully Completes Phase I/II Colon Cancer Trial with Gastrimmune.
Business Wire; Mar 29, 1996; 700+ Words ...BUSINESS WIRE)--March 29, 1996--Aphton announced the successful completion of...an expected lifetime of only 22 weeks. Aphton's President and Chief Executive Officer...demonstrating safety and of demonstrating that Aphton's innovative technology worked in humans...
Aphton Corp.-Deals & Alliances Report.
M2 Presswire; Feb 2, 2009; 700+ Words ...2 February 2009-www.companiesandmarkets.com: Aphton Corp.-Deals & Alliances Report(C)1994-2009...02022009 -www.companiesandmarkets.com adds new report: Aphton Corp.-Deals & Alliances Report Deals & Alliances...
Other News To Note.(Amarillo Biosciences Inc)(BioWa Inc. signs a contract with Aphton Corp)(Evotec AG signed a deal with Apeiron Biologics GmbH)
BIOWORLD Today; Feb 15, 2006; 700+ Words ...BioWa Inc., of Princeton, N.J., and Aphton Corp., of Philadelphia, signed a deal granting Aphton's wholly owned subsidiary, Igeneon, a...milestones and potential royalties. Geron Corp., of Menlo Park, Calif., and Cambrex...
Aphton Corp. (Active Pharmaceutical Ingredient Watch).(FDA grants fast track status for immunogen in combination with cisplatin and 5-FU for stage IV gastric cancer)(Brief Article)
Chemical Market Reporter; Mar 3, 2003; 576 Words APHTON Corp.'s GI7DT (anti-gastin) immunogen in combination with cisplatin and 5-FU for use in stage IV gastric cancer has been granted fast track status by the Food and Drug Administration (FDA).
Other News To Note.(Aphton Corp. reports positive results for metastatic stomach cancer treatment)(Government Activity)(Statistical Data Included)
BIOWORLD Today; Jun 13, 2002; 700+ Words ...1.07. Advanced Viral Research Corp., of Yonkers, N.Y., said its...Foster City, Calif., an Applera Corp. business, to verify the existence...Financial terms were not disclosed. Aphton Corp., of Miami, reported positive interim...
Promotiions at Aphton Corp.(Patrick Mooney, Dov Michaeli)
Pharma Marketletter; Feb 9, 2004; 350 Words US biopharmaceutical company Aphton Corp says it has promoted Patrick Mooney, formerly chief medical officer, to the posts of president, chief executive and director...
Receptor BioLogix Acquires Late-Stage Cancer Drug from Aphton Corp.
PR Newswire; Jul 31, 2006; 700+ Words ...announced today that it has acquired the cancer vaccine Insegia(TM), and related assets, from Philadelphia-based Aphton Corp. (Pink Sheet: APHTQ) in a Chapter 11 bankruptcy sale that was recently approved by the U.S. Bankruptcy Court...
Aphton Corp. (NASDAQ:APHT).(chief executive officer selected)(Brief Article)
Biomedical Market Newsletter; May 31, 2003; 513 Words MIAMI FL -- Patrick T. Mooney, MD, is its new Chief Medical Officer, reporting to Philip Gevas, CEO.
APHTON'S INSEGIA MISSES IN PANCREATIC CANCER PHASE III.(Aphton Corp)
BIOWORLD Today; Feb 16, 2005; ; 700+ Words ...Karen Pihl-Carey, Staff Writer Aphton Corp.'s stock fell more than 45 percent...long-lived control group, said Aphton CEO Patrick Mooney. "Based on this...fall in stock price might affect Aphton's acquisition of Vienna, Austria...
EYEING CANCER DRUGS, APHTON ACQUIRING IGENEON FOR $81M.
BIOWORLD Today; Dec 16, 2004; ; 700+ Words ...Karen Pihl-Carey, Staff Writer Aphton Corp. entered a definitive agreement...million in equity. By doing so, Aphton is bulking up its clinical pipeline...Insegia. Since Patrick Mooney became Aphton's president and CEO last February...
Aphton Ends Sanofi Deal, Seeks New Insegia Partner.
BIOWORLD Today; Nov 11, 2005; ; 700+ Words ...Byline: Jennifer Boggs, Staff Writer Aphton Corp. agreed to terminate its co-promotion...eliminating two major overhangs" for Aphton, said Patrick Mooney, chairman...then Aventis Pasteur) called for Aphton to bear all the development and regulatory...
APHTON RAISES $16M PRIVATELY TO FUND PHASE III CANCER STUDY.(Brief Article)
BIOWORLD Today; Apr 13, 2000; ; 700+ Words ...of metastatic pancreatic cancer, Aphton Corp. raised $16.22 million from a...biotechnology and health care funds. Aphton placed 491,515 shares of common...with less advanced disease. "In Aphton's Phase II data, there was an...
Aphton Bankruptcy News Blasts Stock; Igeneon Also Facing Risk.
BIOWORLD Today; May 25, 2006; ; 700+ Words ...Coast Editor The sliding fortune of Aphton Corp. shifted seismically for the worse...filed for Chapter 11 bankruptcy. Aphton's stock (Pink Sheets:APHT...in November, and Nasdaq delisted Aphton's shares in January. (See BioWorld...
APHTON PLACEMENT GETS $20M; AVENTIS DEAL WILL NOT CHANGE.
BIOWORLD Today; Apr 2, 2003; ; 700+ Words ...Bolstered by $20 million in financing, Aphton Corp. said it will not restructure its...not specify how. A spokeswoman for Aphton said the Miami-based firm had no...private placement "will allow [Aphton] to operate into the first quarter...
Increased Survival Results of Advanced Colorectal Cancer Patients in Phase I/II Clinical Trial Announced by Aphton.
Business Wire; Jan 22, 1998; 700+ Words ...at an international Clinical Oncology meeting. Aphton Corp. is a biopharmaceutical company developing products...research analysts, can be visited at: www.aphton.com . CONTACT: Aphton Corp. J. L. Whitmore, 530/666-5226
242 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives